newsfilter
← Latest News
PR Newswire·

Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022

NEW YORK, Nov. 23, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases,